source
- Corxel opts for SPAC merger to take oral obesity drug public on NasdaqCorxel Pharmaceuticals, an obesity-focused biotech, said it will merge with Amanat Acquisition in the first half of next year to become a publicly traded company on Nasdaq. The company’s CFO noted…
- Lycia Therapeutics raises $317.5 million in upsized Nasdaq IPO as Windward Bio eyes listingLycia Therapeutics completed an initial public offering on Nasdaq, selling shares that generated roughly $317.5 million after the offering was upsized. The company’s debut on the exchange marks a…